TrialCancer2025

Cost-effectiveness of office-based, magnetic resonance imaging-guided transperineal versus transrectal prostate biopsy: An economic analysis of the PREVENT trial.

Mitchell M Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.